The human papillomavirus (HPV) vaccine has been controversial since its approval in 2006. In the United States, several campaigns have spread myths about its safety and necessity. Consequently, 26 percent of American parents who declined the vaccine in 2019 did so because of safety concerns, up from only 5 percent in 2008. In 2018, the U.S. Department of Health and Human Services set a goal of vaccinating 80 percent of adolescents against HPV by…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The human papillomavirus (HPV) vaccine has been controversial since its approval in 2006. In the United States, several campaigns have spread myths about its safety and necessity. Consequently, 26 percent of American parents who declined the vaccine in 2019 did so because of safety concerns, up from only 5 percent in 2008. In 2018, the U.S. Department of Health and Human Services set a goal of vaccinating 80 percent of adolescents against HPV by…